Publication | Open Access

Structure-based drug design using GPCR homology modeling: Toward the discovery of novel selective CysLT2 antagonists

Molecular DockingDrug TargetBiochemistryDrug DesignMedicineNatural SciencesGpcr Homology ModelingStructure-based Drug DesignRational Drug DesignNon-peptide LigandPharmacologyMolecular ModelingDrug Discovery